Nine Square Therapeutics

About:

Nine Square Therapeutics is a developer of novel therapies for movement disorders.

Website: https://www.ninesquaretx.com/

Top Investors: Apple Tree Partners, Michael J. Fox Foundation

Description:

Nine Square Therapeutics is discovering new small-molecule therapeutics for degenerative movement disorders including Parkinson’s disease and amyotrophic lateral sclerosis (ALS), as well as non-degenerative disorders such as essential tremor and dyskinesias, by integrating computational chemistry, biophysics, and computational biology into machine-learning-enabled cell profiling platforms for target identification, chemical optimization, and patient stratification. It was founded in 2020 and headquartered in New York, United States.

Total Funding Amount:

$54.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2020-01-01

Founders:

Lani Wu, Matthew Jacobson, Spiros Liras, Steven Altschuler

Number of Employees:

101-250

Last Funding Date:

2023-09-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai